Cargando…
Proteasome inhibitor-induced cleavage of HSP90 is mediated by ROS generation and caspase 10-activation in human leukemic cells
Heat shock protein 90 (HSP90) is a molecular chaperone that supports the stability of client proteins. The proteasome is one of the targets for cancer therapy, and studies are underway to use proteasome inhibitors as anti-cancer drugs. In this study, we found that HSP90 was cleaved to a 55 kDa prote...
Autores principales: | Park, Sangkyu, Park, Jeong-A, Yoo, Hwanmin, Park, Han-Bum, Lee, Younghee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512190/ https://www.ncbi.nlm.nih.gov/pubmed/28715732 http://dx.doi.org/10.1016/j.redox.2017.07.010 |
Ejemplares similares
-
Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019) -
Physical plasma-triggered ROS induces tumor cell death upon cleavage of HSP90 chaperone
por: Bekeschus, Sander, et al.
Publicado: (2019) -
Inhibition of MUC1-C Increases ROS and Cell Death in Mouse Embryonic Stem Cells
por: Park, Jeong-A, et al.
Publicado: (2020) -
Hsp90 Chaperones Bluetongue Virus Proteins and Prevents Proteasomal Degradation
por: Mohl, Bjorn-Patrick, et al.
Publicado: (2019) -
Enhancing viability and angiogenic efficacy of mesenchymal stem cells via HSP90α
and HSP27 regulation based on ROS stimulation for wound healing
por: Seo, Inwoo, et al.
Publicado: (2023)